blood sugar and A1C Ozempic mimics a natural hormone, GLP-1, to improve blood sugar (glucose) in adults with type 2 diabetes along with diet and exercise, which may contribute to weight loss of up to 5-6% of body weight on average.* major heart events and kidney disease The FDA has approved Ozempic to reduce the risk of major cardiovascular events like stroke or heart attack, in adults with type 2 diabetes and heart disease
We are here to provide the tools, the technology, and the clinical expertise to make that journey as clear and supported as possible
This is off-label and not supported by RCT data
93 HampeC
A 2025 meta-analysis of 12 RCTs involving more than 25,000 participants showed no elevated risk of any cancer type, including thyroid (RR 1.07, 0.225.12 p = 0.93), pancreatic (RR 0.85, 0.107.43 p = 0.89), or gastrointestinal malignancy (RR 0.73, 0.262.04 p = 0.54) [147]